BANGKOK, Feb 20 (The Nation Thailand/ANN): The mRNA vaccine against the coronavirus developed by Chulalongkorn University of Thailand, is scheduled to enter the first stage of human trials soon, according to a university official.
Kiat Ruxrungtham, who is in charge of the University's vaccine development project, confirmed the mRNA vaccine ChulaCov19 will be put on trial with humans in late April or early May, following satisfactory results of earlier trials with rats and macaques.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
